Thrombosis Associated with Ovarian Hyperstimulation Syndrome in a Carrier of the Factor V Leiden Mutation

• References

• 1 Aurousseau MH, Samama MM, Belhassen A, Herve F, Hugues JN. Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports. Hum Reprod 1995; 10: 94-97
• 2 Rizk B, Meagher S, Fisher AM. Severe ovarian hyperstimulation syndrome and cerebrovascular accidents. Hum Reprod 1990; 5: 697-688
• 3 Schenker JG, Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 1978; 30: 255-268
• 4 Aune B, Høie KE, Øian P, Holst N, Østerud B. Does ovarian stimulation for in-vitro fertilization induce a hypercoagulable state?. Hum Reprod 1991; 6: 925-927
• 5 Phillips LL, Gladstone W, vande Wiele R. Studies of the coagulation and fibrinolytic systems in hyperstimulation syndrome after administration of human gonadotropins. J Reprod Med 1975; 14: 138-143
• 6 Kaaja R, Siegberg R, Tiitinen A, Koskimies A. Severe ovarian hyperstimulation syndrome and deep venous thrombosis. Lancet 1989; 02: 1043
• 7 Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522
• 8 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134
• 9 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
• 10 Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users carriers of factor V Leiden mutation. Lancet 1994; 344: 1453-1457
• 11 Cumming AM, Tait RC, Fildes S, Yoong A, Keeney S, Hay CRM. Development of resistance to activated protein C during pregnancy. Br J Haematol 1995; 90: 725-727
• 12 Foumet N, Surrey E, Kerin J. Internal jugular vein thrombosis after ovulation induction with gonadotropins. Fertil Steril 1991; 56: 354-356
• 13 Ong ACM, Eisen V, Rennie DP, Homburg R, Lachelin GCL, Jacobs HS, Slater JDH. The pathogenesis of the ovarian hyperstimulation syndrome (OHS): a possible role for ovarian renin. Clin Endocrinol 1991; 34: 43-49
• 14 Mills MS, Eddowes HA, Fox R, Wardle PG. Subclavian vein thrombosis: a late complication of ovarian hyperstimulation syndrome. Hum Reprod 1992; 7: 370-371
• 15 Bénifla J-L, Conard J, Naouri M, Darai E, Bascou V, Neuraz A, Deval B, Gugliemina J-N, Crequat J, Madelenat P. Syndrome d’hyperstimulation ovarienne et thrombose. A propos d’un cas de thrombose de la veine jugu-laire interne. Revue de la litterature. J Gynecol Obstet Biol Reprod 1994; 28: 778-783
• 16 Bachmeyer C, Grateau G, Bruel D, Sereni D. Thrombose de la veine jugulaire interne au cours d’un syndrome d’hyperstimulation ovarienne. Rev Méd Interne 1994; 15: 52-54
• 17 Hignett M, Spence JEH, Claman P. Internal jugular vein thrombosis: a late complication of ovarian hyperstimulation syndrome despite mini-dose heparin prophylaxis. Hum Reprod 1995; 10: 121-123
• 18 Kligman I, Noyes N, Benadiva CA, Rosenwaks Z. Massive deep vein thrombosis in a patient with antithrombin III deficiency undergoing ovarian stimulation for in vitro fertilization. Fertil Steril 1995; 63: 673-676
• 19 Horstkamp B, Liibke M, Kentenich H, Riess H, Büsscher U, Lichtenegger W. Internal jugular vein thrombosis caused by resistance to activated protein C as a complication of ovarian hyperstimulation after in vitro fertilization. Hum Reprod 1996; 11: 280-282